Cancer cells that have broken away from a primary tumor can lurk in the body for years in a dormant state, evading immune defenders and biding their time until conditions are ripe for establishing a ...
Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...
Using single-cell epigenomic profiling of immune cells from 110 individuals, researchers show that genetic variation and ...
The cancer gene MYC camouflages tumours by suppressing alarm signals that normally activate the immune system. This finding from a new study offers a ...
LA JOLLA (January 8, 2025)—Human bodies defend themselves using a diverse population of immune cells that circulate from one organ to another, responding to everything from cuts to colds to cancer.
Scientists have long observed that cancer patients have a lower risk of Alzheimer’s disease. New research reveals a possible reason why.
Immune complex-mediated membranoproliferative glomerulonephritis (IC-MPGN) is a rare disease that affects the filtering units in your kidneys (glomeruli). There are many types of glomerular diseases.
New Memorial Sloan Kettering Cancer Center research reveals how dormant metastatic cancer cells protect themselves from the immune system by changing their shape.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results